The FDA approved Wegovy for use in a form of liver disease.
www.marketwatch.com
#Novo #Nordisk #shares #rising #FDA #approves #Wegovy
Novo Nordisk shares are rising. The FDA approves another use for Wegovy.
Related Posts
Saks acquisition of Neiman Marcus led to bankruptcy
An entrance to the Saks Fifth Avenue flagship store in New York on Jan. 14, 2026, after the company filed…
Ares Management Corp (ARES) Deepening Exposure to the AI Space
Ares Management Corp (NYSE:ARES) is one of the best NYSE stocks to buy for the long term. On February 10,…
Jefferies Cuts Virtu (VIRT) Target to $49, Maintains Buy Rating
Virtu Financial, Inc. (NYSE:VIRT) is one of the most undervalued financial stocks to buy according to Wall Street analysts. On…